Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Lupus
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Lupus
    TopAbstracts in Lupus 06/22/2009 - (DGNews)
    TopAbstracts in Lupus 06/08/2009 - (DGNews)
    TopAbstracts in Lupus 05/25/2009 - (DGNews)
    TopAbstracts in Lupus 05/11/2009 - (DGNews)
    TopAbstracts in Lupus 04/27/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Lupus
    • The State of the Science in Managing Systemic Lupus Erythematosus: Update From EULAR 2008
    • The Faces of SLE: Assessing Disease Activity, Response to Therapy, and Control of Comorbidities
      Advances in B-Cell Biology in the Treatment of Autoimmune and Inflammatory Diseases
      Neuroinflammatory Diseases in Rheumatology
      Neurological, Psychological or Psychiatric Dysfunction in Patients with SLE

      Webcasts/CME archive

       Recent cases - Lupus
        Primary Osteosarcoma of the Urinary Bladder Following Cyclophosphamide Therapy for Systemic Lupus Erythematosus: A Case Report
        Lupus-Associated Vasculitis Manifesting as Acute Appendicitis in a 16 Year Old Girl
        Rhupus Arthropathy as the Presenting Manifestation in Juvenile SLE: A Case Report
        Rapidly Evolving Purpuric Lesions to Massive Hemorrhagic Bullae, with Rapid Improvement by Prednisolone: as a Coetaneous Manifestation of Systemic Lupus Erythematosus: A Case Report
        Life Threatening Pneumonia in a Lupus Patient: A Case Report

        Cases archive
          




        my personal edition > lupus > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Men With Systemic Lupus Erythematosus Fare Worse Than Women, Study Confirms

        By Maggie Schwarz

        WASHINGTON, DC -- November 13, 2006 -- Male gender is a strong predictor of target organ damage in systemic lupus erythematosus (SLE) early in the course of disease, according to a study reported here at the American College of Rheumatology - Association of Rheumatology Health Professionals Annual Scientific Meeting (ACR-ARHP).

        "Men with SLE should be treated more aggressively, earlier in their disease," asserted Rosa M. Andrade, MD, research post-doctoral fellow, University of Alabama, Birmingham, Alabama, in a presentation on November 12th.

        Men are believed to suffer more renal, neurological, and cardiovascular involvement than do women but no clinical studies have confirmed or denied this belief. Dr. Andrade and colleagues therefore set out to determine the whether gender plays any role in severity of SLE. The investigators believed their institution was an excellent site to study SLE longitudinally because it has a multiethnic patient population. They studied the cohort for 10 years.

        The study enrolled patients with SLE 16 years and older and had disease duration no greater than 5 years at enrollment. The cohort consisted of Hispanics, African Americans and Caucasians. Socioeconomic-demographic, clinical and serological manifestations as well as disease activity (SLAM-R) and damage accrual (SLICC damage index or SDI) were compared between male and female patient groups.

        Sixty-three male SLE patients (10.2%) from all ethnic groups were included. Mean ages for male and female patients were comparable.

        Caucasians, smokers, alcohol drinkers, presence of positive lupus anticoagulant (LAC) and renal involvement were more frequent among male patients, whereas musculoskeletal involvement was less common. Time to accrual of ACR criteria and disease duration were shorter in male patients; damage was more common and of higher magnitude in men.

        Positive LAC, shorter disease duration and higher early damage were independently associated with male SLE. Male gender was a strong predictor of damage, early in the course of disease.
        Dr. Andrade concluded that, though men and women with SLE appeared similar in their clinical profiles, men accrued ACR criteria for SLE 17 months earlier than women and entered the cohort with greater baseline organ damage.

        "Men require higher doses of prednisone and generally do worse than women, not specifically in any particular organ system but overall," Dr. Andrade stated.


        [Presentation title: Andrade: Accelerated Damage Accrual Among Male System Lupus Erythematosus Patients: Results From a Multiethnic US Cohort. Abstract 557]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send